Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alx Oncology Holdings Inc (NQ: ALXO )

4.870 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.870
Bid (Size) 4.560 (1)
Ask (Size) 24.80 (2)
Prev. Close 4.870
Today's Range 4.870 - 4.870
52wk Range 4.520 - 19.85
Shares Outstanding 40,863,049
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ALX Oncology and Quantum Leap Healthcare Collaborative™ Announce First Patient Dosed in the I-SPY-P1 TRIAL in Breast Cancer
From ALX Oncology
Via Globe NewsWire
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
From ALX Oncology
Via Globe NewsWire

Performance

YTD
-56.52%
-56.52%
1 Month
-31.50%
-31.50%
3 Month
-52.72%
-52.72%
6 Month
-53.97%
-53.97%
1 Year
-73.73%
-73.73%

More News

Read More
ALX Oncology Announces First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer
From ALX Oncology
Via Globe NewsWire
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023
From ALX Oncology
Via Globe NewsWire
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ALX Oncology
Via Globe NewsWire
AMC Preferred Equity Units, Accolade And Some Other Big Stocks Moving Higher On Friday
Via Benzinga
ALX Oncology Announces Initial Data from ASPEN-05 Study of Evorpacept in Combination with Azacitidine and Venetoclax, Demonstrating Tolerability and Preliminary Activity in Patients with Acute Myeloid Leukemia
From ALX Oncology
Via Globe NewsWire
ALX Oncology Appoints Scott Garland to its Board of Directors
From ALX Oncology
Via Globe NewsWire
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
From ALX Oncology
Via Globe NewsWire
ALX Oncology to Present New Clinical Data on Evorpacept in Acute Myeloid Leukemia at 64th ASH Annual Meeting
From ALX Oncology
Via Globe NewsWire
ALX Oncology Announces Upcoming Investor Conference Participation
From ALX Oncology
Via Globe NewsWire
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
From ALX Oncology
Via Globe NewsWire
ALX Oncology Announces Trials in Progress Abstracts Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From ALX Oncology
Via Globe NewsWire
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
Via Benzinga
ALX Oncology Shares Gain As FDA Grants Fast Track Status To Head And Neck Cancer Candidate
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
Via Benzinga
ALX Oncology Shares Soar As FDA Grants Orphan Drug Status To Blood Cancer Candidate
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.